Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Eur Rev Med Pharmacol Sci ; 26(24): 9467-9472, 2022 12.
Article in English | MEDLINE | ID: mdl-36591855

ABSTRACT

OBJECTIVE: The fibrosis can be detected using non-invasive methods including prolidase activity, proline levels and galectin-3 (GAL-3) detection in the serum. The aim of this study was to investigate the liver fibrosis through non-invasive methods in chronic hepatitis B patients. PATIENTS AND METHODS: This prospective case control study includes 56 patients with Chronic Active Hepatitis B (CAHB), 57 patients with Inactive Hepatitis B (IHB), and 60 healthy matched control subjects. The first group included the CAHB [hepatitis B surface antigen (HBsAg): positive; HBV DNA >2,000 IU/mL; normal or high alanine aminotransferase (ALT) value] undergo a liver biopsy, while the second group included the IHB (HBsAg: positive; HBV DNA: negative; normal ALT value). The third group comprised the healthy controls. Serum prolidase enzyme activities (SPEA), proline and galectin-3 levels were measured for each group. RESULTS: Patients with CAHB had significantly higher SPEA levels (1,004.3±186.8 IU/L) than did the controls (196.5±306 IU/L) (p<0.001). Significantly higher serum GAL-3 levels were found in the CHB group compared with HBV carrier and the control groups (27.4±32.2 ng/mL, 6.5±13.4 ng/mL, 3.1±5.7 ng/mL, respectively, p<0.001). The relationship between serum prolidase activity, hidroxiprolyne and fibrosis (p<0.05). There were no significant differences in ALT levels between inactive HBV carriers and the control groups (p>0.05). CONCLUSIONS: We suppose that hidroxiprolyne levels and prolidase enzyme activity might be an indicator as a marker for fibrosis in CAHB and the evaluation of response to treatment.


Subject(s)
Hepatitis B, Chronic , Humans , Hepatitis B, Chronic/diagnosis , Hepatitis B Surface Antigens , DNA, Viral , Galectin 3 , Case-Control Studies , Liver Cirrhosis/diagnosis , Galectins , Alanine Transaminase , Hepatitis B virus/genetics , Hepatitis B e Antigens
2.
Eur Rev Med Pharmacol Sci ; 19(14): 2711-6, 2015.
Article in English | MEDLINE | ID: mdl-26221904

ABSTRACT

OBJECTIVE: There are very few studies that compare the snakebite cases in children and adults. The present study aimed to compare the demographic characteristics, clinical presentations, laboratory findings, and developed complications in pediatric and adult patients due to snakebites. PATIENTS AND METHODS: This study included the patients admitted to the hospital and monitored due to snakebite between July 1999 and December 2012. The condition of each patient who had been bitten was admitted to the hospital was monitored from the time of admission to the end of their hospital stay. The fact that a snakebite occurred was recorded if the subjects saw the snake or if the appearance of the puncture sites was convincingly a snakebite. RESULTS: The present work included 290 patients, of whom 123 were children and 167 were adults. The most common location of the bites was the lower extremity with 78.9% (n=97) and 63.5% (n=106) in pediatric and adult patients, respectively. All of the pediatric patients received prophylactic treatment with antibiotics, whereas 62 (37.1%) adult patients received antimicrobial treatments due to the soft tissue infection. The most common complication developed was pulmonary edema in children at a rate of 33.3% (n=41) and compartment syndrome in adult patients at a rate of 3% (n=5). CONCLUSIONS: Patients admitted to the hospital due to snakebite should be monitored for at least 12 hours, even if there is no sign of clinical envenomation. Antivenom treatment should be administered to the patients requiring clinical staging. Patients should be kept under close monitoring to prevent the development of serious complications such as cellulitis, pulmonary edema, compartment syndrome, and disseminated intravascular coagulation.


Subject(s)
Hospitalization/trends , Snake Bites/diagnosis , Snake Bites/therapy , Adolescent , Adult , Antivenins/therapeutic use , Child , Female , Humans , Intensive Care Units/trends , Length of Stay/trends , Male , Middle Aged , Physical Examination/methods , Physical Examination/trends , Snake Bites/complications
4.
Clin Microbiol Infect ; 20(11): O847-53, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24831227

ABSTRACT

This study reviewed the clinical, laboratory, therapeutic and prognostic data on genitourinary involvement of brucellosis in this largest case series reported. This multicentre study pooled adult patients with genitourinary brucellar involvement from 34 centres treated between 2000 and 2013. Diagnosis of the disease was established by conventional methods. Overall 390 patients with genitourinary brucellosis (352 male, 90.2%) were pooled. In male patients, the most frequent involved site was the scrotal area (n=327, 83.8%), as epididymo-orchitis (n=204, 58%), orchitis (n=112, 31.8%) and epididymitis (n=11, 3.1%). In female patients, pyelonephritis (n=33/38, 86.8%) was significantly higher than in male patients (n=11/352, 3.1%; p<0.0001). The mean blood leukocyte count was 7530±3115/mm3. Routine laboratory analysis revealed mild to moderate increases for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). The mean treatment duration and length of hospital stay were significantly higher when there were additional brucellar foci (p<0.05). Surgical operations including orchiectomy and abscess drainage were performed in nine (2.3%) patients. Therapeutic failure was detected in six (1.5%), relapse occurred in four (1%), and persistent infertility related to brucellosis occurred in one patient. A localized scrotal infection in men or pyelonephritis in women in the absence of leucocytosis and with mild to moderate increases in inflammatory markers should signal the possibility of brucellar genitourinary disease.


Subject(s)
Brucellosis/drug therapy , Brucellosis/pathology , Female Urogenital Diseases/drug therapy , Female Urogenital Diseases/pathology , Male Urogenital Diseases/drug therapy , Male Urogenital Diseases/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Brucellosis/diagnosis , Female , Female Urogenital Diseases/diagnosis , Humans , Male , Male Urogenital Diseases/diagnosis , Middle Aged , Prognosis , Retrospective Studies , Young Adult
5.
Clin Microbiol Infect ; 20(2): O75-82, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24118178

ABSTRACT

We evaluated the efficacy and tolerability of antibiotic regimens and optimal duration of therapy in complicated and uncomplicated forms of spinal brucellosis. This is a multicentre, retrospective and comparative study involving a total of 293 patients with spinal brucellosis from 19 health institutions. Comparison of complicated and uncomplicated spinal brucellosis was statistically analysed. Complicated spinal brucellosis was diagnosed in 78 (26.6%) of our patients. Clinical presentation was found to be significantly more acute, with fever and weight loss, in patients in the complicated group. They had significantly higher leukocyte and platelet counts, erythrocyte sedimentation rates and C-reactive protein levels, and lower haemoglobulin levels. The involvement of the thoracic spine was significantly more frequent in complicated cases. Spondylodiscitis was complicated, with paravertebral abscess in 38 (13.0%), prevertebral abscess in 13 (4.4%), epidural abscess in 30 (10.2%), psoas abscess in 10 (3.4%) and radiculitis in 8 (2.7%) patients. The five major combination regimens were: doxycycline 200 mg/day, rifampicin 600 mg/day and streptomycin 1 g/day; doxycycline 200 mg/day, rifampicin 600 mg/day and gentamicin 5 mg/kg; doxycycline 200 mg/day and rifampicin 600 mg/day; doxycycline 200 mg/day and streptomycin 1 g/day; and doxycycline 200 mg/day, rifampicin 600 mg/day and ciprofloxacin 1 g/day. There were no significant therapeutic differences between these antibiotic groups; the results were similar regarding the complicated and uncomplicated groups. Patients were mostly treated with doxycycline and rifampicin with or without an aminoglycoside. In the former subgroup, complicated cases received antibiotics for a longer duration than uncomplicated cases. Early recognition of complicated cases is critical in preventing devastating complications. Antimicrobial treatment should be prolonged in complicated spinal brucellosis in particular.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Brucellosis/drug therapy , Spondylitis/drug therapy , Abscess/drug therapy , Abscess/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Aminoglycosides/administration & dosage , Brucellosis/complications , Brucellosis/pathology , Doxycycline/administration & dosage , Drug Therapy, Combination/methods , Female , Humans , Male , Middle Aged , Retrospective Studies , Rifampin/administration & dosage , Spondylitis/complications , Spondylitis/pathology , Treatment Outcome , Young Adult
6.
Clin Ter ; 164(6): 537-41, 2013.
Article in English | MEDLINE | ID: mdl-24424220

ABSTRACT

AIM: In developing countries HAV infection is very common in the first years of life and it is often asymptomatic. However especially in regions of intermediate endemicity, exposure to the virus may delay and outbreaks of hepatitis A may be encountered in adults. The aim of this study is to evaluate the clinical and laboratory findings and risk factors of adults with acute viral hepatitis A. MATERIALS AND METHODS: In present study we evaluated 203 patient with acute viral hepatitis A, who were admitted to four different hospitals of three cities of Turkey between January 2000-December 2011, retrospectively. The diagnosis of acute viral hepatitis A was performed by laboratory findings and clinically. RESULTS: In a total of 203 patients, 120 (59.1%) patients were male and 83 (40.9%) were female. Mean age of cases with acute viral hepatitis A was 24.7 +11.8 years (ranged 15 to 82 years old). Acute viral hepatitis A were seen in patient who were 15-20 years and 21-30 years old, commonly. Jaundice (74%), fatigue (68%), nausea- vomiting (56%) and dark urine (48%) were the most common symptoms in cases. Prolonged cholestasis (6.8%) was the most common atypical manifestation. Prolonged jaundice was more frequent in the cases with positive HBsAg (P < 0.001). CONCLUSIONS: Acute viral hepatitis A can cause atypical presentations such as prolonged cholestasis, acute kidney injury and fulminant hepatitis. Some precautions such as routine vaccination program, improvement of hygiene conditions and informing people about it, should be taken for reducing of acute viral hepatitis A infection incidence.


Subject(s)
Acute Kidney Injury/virology , Hepatitis A/epidemiology , Hospitalization , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Female , Hepatitis A/physiopathology , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Risk Factors , Turkey/epidemiology , Young Adult
7.
Int J Clin Pract ; 64(7): 900-7, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20584223

ABSTRACT

OBJECTIVE: This study was designed to determine the relationship between serum uric acid level and the presence and severity of coronary artery disease (CAD). METHODS: A total of 1012 patients who underwent coronary angiography were included in this study. All patients were assessed for the presence of cardiovascular risk factors and ongoing medications. Serum uric acid and creatinine level, as well as a fasting lipid profile and fasting blood glucose, were measured in all patients before the procedure. The severity of CAD was assessed by the Gensini score. RESULTS: Of 1012 patients (mean age, 59.4 +/- 10.24 years), 680 were men (mean age, 58.7 +/- 10.5 years) and 332 were women (mean age, 61.0 +/- 9.51 years). Of the study patients, 703 (69%) were hypertensive, 292 (28.9%) were diabetic (DM), 304 (30%) had a smoking history, 306 (30%) had low high-density lipoprotein cholesterol levels and 350 (34%) had hypertriglyceridaemia. CAD was present in 689 (68%) patients who were assessed by coronary angiography. One-, two- and three-vessel disease was detected in 32.6%, 32.5% and 34.9% of the patients respectively; left main coronary artery lesion was detected in 15% of the patients. A statistically significant difference in the mean uric acid concentrations was found between the patients with or without CAD [380 +/- 121 micromol/l (6.39 +/- 2.04 mg/dl) vs. 323.5 +/- 83.2 micromol/l (5.44 +/- 1.40 mg/dl) p < 0.001]. Based on logistic regression analysis, the increased serum uric acid level was found to be associated with the presence of CAD in both men and women (p < 0.001). The increased serum uric acid level was also found to be associated with the severity of CAD in both men and women based on multivariate linear regression analysis (p < 0.001). CONCLUSION: In conclusion, serum uric acid level was found to be associated with the presence and severity of CAD.


Subject(s)
Coronary Artery Disease/blood , Uric Acid/metabolism , Aged , Coronary Angiography , Coronary Artery Disease/diagnostic imaging , Female , Humans , Male , Middle Aged , Risk Factors
8.
Int J Clin Pract ; 64(4): 518-22, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20456197

ABSTRACT

OBJECTIVES: Sibutramine is a selective inhibitor of the reuptake of monoamines. Plasma levels of brain natriuretic peptide (BNP) appear to be inversely associated with body mass index (BMI) in subjects with and without heart failure for reasons that remain unexplained. The aim of this study was to investigate the possible influence of sibutramine treatment on BNP levels in severely obese patients. METHODS: Fifty-two severely obese female patients with BMI > 40 kg/m(2) were included to this study. The women were recommended to follow a weight-reducing daily diet of 25 kcal/kg of ideal body weight. During the treatment period, all patients were to receive 15 mg of sibutramine once a day. Blood chemistry tests were performed before the onset of the medication and after 12 weeks of treatment. RESULTS: None of the subjects was withdrawn from the study because of the adverse effects of sibutramine. Body weight (108.8 +/- 13.3 kg vs. 101.7 +/- 15.6 kg, p < 0.001), BMI (44.6 +/- 4.6 kg/m(2) vs. 41.8 +/- 5.7 kg/m(2), p < 0.001) and BNP [8.6 (0.5-49.5) ng/l vs. 3.1 (0.2-28.6) ng/l, p = 0.018] levels were significantly decreased after 12 weeks of sibutramine treatment. Total cholesterol (5.19 +/- 0.90 mmol/l vs. 4.82 +/- 1.05 mmol/l respectively; p < 0.001), low-density lipoprotein-cholesterol (3.26 +/- 0.86 mmol/l vs. 2.99 +/- 0.40 mmol/l respectively; p = 0.008), levels were significantly decreased; however, there was no significant alteration in high-density lipoprotein-cholesterol and triglyceride levels. CONCLUSION: This study has shown a decrease in BNP levels which may lead to improvement in cardiac outcome after sibutramine treatment. Further randomised studies are needed to be conducted to clarify the relationship between sibutramine and BNP.


Subject(s)
Appetite Depressants/therapeutic use , Cyclobutanes/therapeutic use , Natriuretic Peptide, Brain/metabolism , Obesity/drug therapy , Biomarkers/metabolism , Body Mass Index , Cholesterol, LDL/metabolism , Female , Humans , Male , Middle Aged
9.
Vet Parasitol ; 170(3-4): 287-90, 2010 Jun 24.
Article in English | MEDLINE | ID: mdl-20303667

ABSTRACT

The acaricidal activity of a volatile essential oil hydrodistillate of Satureja thymbra L. (Lamiaceae) and its major constituents, carvacrol and gamma-terpinene, were evaluated against field-collected unfed adult Hyalomma marginatum. The distillate was tested against this tick species at 5, 10, 20, and 40 microL/L while the two major components were each tested at 10 microL/L. Generally, tick mortality to the S. thymbra distillate increased with concentration and exposure time. Ticks exposed to vapors from cotton wicks containing at least 40 microL/L resulted in complete (100%) mortality at 3h. The lower concentrations provided >or=90% mortality at 3h post treatment with complete mortality at 24h. Knockdown was observed only in the carvacrol and gamma-terpinene treatments. Ticks exposed to carvacrol-treated wicks produced >93% knockdown at 3h but at 24h approximately 57% were dead. The gamma-terpinene treatment produced >or=90% knockdown at 105 min through 3h but at 24h only about 87% of the ticks were dead.


Subject(s)
Ixodidae/drug effects , Monoterpenes/pharmacology , Oils, Volatile/pharmacology , Plant Oils/pharmacology , Satureja/chemistry , Acaricides/chemistry , Acaricides/pharmacology , Animals , Cyclohexane Monoterpenes , Cymenes , Monoterpenes/chemistry , Oils, Volatile/chemistry , Plant Components, Aerial/chemistry , Plant Oils/chemistry
10.
Iran J Public Health ; 39(3): 102-8, 2010.
Article in English | MEDLINE | ID: mdl-23113028

ABSTRACT

BACKGROUND: To compare the effectiveness of 3 commercial gel bait formulations containing fipronil (Goliath(©) Cockroach Gel 0.05% AI), chlorpyrifos-A (Clean Bait(©) Gel, 2% AI), and chloropyrifos-B (Serpa(©) Gel 2% AI) against German cockroaches (Blattella germanica) when stored at 23(°)C and 30(°) C after treatment. METHODS: Laboratory bioassays consisted of placing groups of fifteen cockroaches (a random combination of adult, mixed sex and large nymphs-stage 6) into a 5 L cylindrical plastic container with one drop of product (avg 0.10 g ± 0.01 g) applied to a 76 mm x 26 mm glass microscope slide affixed to the bottom of each container (one product tested per container). Cumulative mortality was assessed at 6 h, 1, 2, 3, 4, and 5 d after application. To determine the further effects of storage temperature after treatment on residual activity of the gels, a drop of each product was applied to separate glass microscope slides and stored at either 23(°) C (warm) or 30(°) C (hot) under dark conditions for 0, 1, 7, 14, 30, 45, 60 and 90 d after application. RESULTS: Freshly applied baits (day 0) containing fipronil provided complete cockroach mortality (100%) within 5 d whereas chloryrifos-A and chlorpyrifos-B provided ≈72% and 88% mortality, respectively. Generally, cockroach mortality was greater when gels were stored at 30(°)C compared with 23(°) C. CONCLUSION: The fipronil gel formulation proved to be as efficacious as the chlorpyrifos gels and in some instances surpased the latter formulations depending on storage time and temperature by providing ≈90% mortality at 90 d post treatment.

11.
Inflamm Res ; 58(6): 292-7, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19266265

ABSTRACT

OBJECTIVE: The powerful precept of preoperative risk assessment has been applied to compare the efficacy of leukofiltration techniques for high-risk cohorts with the documentation of broad indicators of systemic inflammation. METHODS: Forty high risk patients were prospectively assigned to four perfusion protocols; the first group (n=10): Polyethyleneoxide (PEO) based heparin bonded extracorporeal circuits (ECC) + Continuous Leukocyte filtration; the second group (n=10): uncoated ECC + leukofiltration; the third group (n=10): PEO based heparin bonded ECC without leukofiltration; and control (n=10). Blood samples were obtained at the following intervals: Baseline (T1), on cardiopulmonary bypass (CPB) (T2), Cross clamp (T3), off CPB (T4), Intensive care unit-24 h (ICU24) (T5), ICU48 (T6). RESULTS: Tumor Necrosis Factor-alpha levels were significantly lower in Group 1 at T3, T4 (p<0.05) vs. control. Procalcitonin levels were significantly lower in Group 1 at T5, T6 (p<0.05) vs. control. Creatinine kinase-MB levels in coronary sinus blood demonstrated well preserved myocardium in filtered+coated (Group 1) and coated groups (Group 3) (p<0.05). Matrix metallopeptidase- 9 and D-Dimer levels in filtered+coated group were significantly lower at T5 and T6 vs. control (p<0.05). CONCLUSION: Leukocyte filtration on coated surfaces alleviated systemic inflammatory response with a better clinical outcome in high risk patients.


Subject(s)
Bacterial Infections/blood , Cardiopulmonary Bypass/adverse effects , Leukocyte Reduction Procedures/methods , Anticoagulants/therapeutic use , Bacterial Infections/immunology , Heparin/therapeutic use , Humans , Inflammation/blood , Inflammation/immunology , Leukocyte Count , Postoperative Complications , Prospective Studies , Risk Assessment , Tumor Necrosis Factor-alpha/blood
12.
Int J Clin Pract ; 62(5): 717-22, 2008 May.
Article in English | MEDLINE | ID: mdl-18266712

ABSTRACT

BACKGROUND: Cardiovascular disease is leading cause of mortality and morbidity in developed and developing countries. Metabolic syndrome (MS) is a risk factor for coronary artery disease (CAD). The effect of MS on angiographic severity of CAD is not well defined. The aim of this study was to examine the effect of MS on angiographic severity of CAD by using Gensini score. METHODS: The total number of 1003 patients who underwent elective coronary angiography in catheter laboratory were included in the study. MS score based on National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) criteria which ranged between zero and five were calculated for each subject. Gensini scores were determined by examining coronary angiograms of the patients. RESULTS: The study population consisted of 634 (63%) male, and 369 (37%) female subjects. The mean age was 59 +/- 11. MS based on NCEP ATP III was present in 246 (25%) patients. CAD was present in 691 patients (69%). The median of Gensini score was five (0-192) in the total sample, 18 (1-192) in the patients with CAD and 25 (0-192) in the patients with MS. A positive correlation was found between MS score and Gensini score (r = 0.402, p < 0.001). CONCLUSIONS: In this study, it was determined that as the severity of MS increases, the angiographic severity of CAD increases as well. Besides, the most important factor on Gensini score was diabetes mellitus in male and hypertension in female subjects.


Subject(s)
Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/etiology , Metabolic Syndrome/complications , Severity of Illness Index , Adult , Aged , Body Constitution , Coronary Angiography , Female , Humans , Male , Middle Aged , Prognosis , Risk Factors
13.
Tissue Cell ; 29(3): 315-21, 1997 Jun.
Article in English | MEDLINE | ID: mdl-18627822

ABSTRACT

The presence of sialic acid (SA) in prothoracic glands (PGs) of Galleria mellonella was determined by the methods of electron microscopy (EM), histochemistry, spectrophotometry (SP) and electronic ionization (EI)-mass spectroscopy. Histochemical observations were carried out by the cationic dye ruthenium red (RR), staining with and without neuraminidase digestion in the larval stage. Neuraminidase-sensitive SA was demonstrated by the decrease in the amount of RR-binding following neuraminidase digestion. The total amount of SA was found to be 0.09016 mg g(-1) in dry tissue by spectrophotometric determination. EI-mass spectroscopy results confirmed the EM and SP observations. The fragmentation scheme derived from EI-mass analysis exhibited the presence of the lactonized form of Neu5Gc7, 9Ac(2). On the basis of the various pieces of evidence described above, it was firmly concluded that Neu5Gc7, 9Ac(2) molecules were present in PGs of G. mellonella.

SELECTION OF CITATIONS
SEARCH DETAIL
...